Tokyo, Aug. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062518) titled 'Evaluation of a Help-Seeking Support Program for Symptom Management in Older Patients with Heart Failure' on Aug. 7.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled

Primary Sponsor: Institute - Osaka Metropolitan University

Condition: Condition - heart failure Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The purpose of this study is to evaluate a help-seeking support program for older patients with heart failure by applying the program to clinical cases. Basic objectives2 - Safety,Efficacy

Intervention: Interventions/Control_1 - Provision of an education and counseling program by expert nurses to facilitate help-seeking among patients with heart failure.

Eligibility: Age-lower limit - 75 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Eligible participants were patients aged 75 years or older with Stage C heart failure who were hospitalized for worsening heart failure and were expected to continue outpatient follow-up at the same institution after discharge. Patients were eligible if the attending physician determined that participation in the study would impose minimal physical and psychological burden. In addition, participants were required to have adequate cognitive function to independently decide whether to participate in the study and to understand and complete the questionnaire. All participants received an explanation of the study and provided written informed consent before enrollment. Key exclusion criteria - Exclusion criteria were as follows: (1) patients with heart failure other than those classified as Stage C according to the ACC/AHA heart failure staging system; (2) patients who were unable to independently decide whether to participate in the study, provide written informed consent, or complete the study questionnaires; and (3) patients who were considered unlikely to complete the intervention or the study questionnaires during scheduled outpatient follow-up visits at 1 month and 3-4 months after hospital discharge. Target Size - 8

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 01 Month 26 Day Date of IRB - 2026 Year 06 Month 26 Day Anticipated trial start date - 2026 Year 08 Month 01 Day Last follow-up date - 2027 Year 09 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071518

Disclaimer: Curated by HT Syndication.